AVITA Medical (RCEL) Payables (2018 - 2025)

AVITA Medical's Payables history runs 8 years deep, the most recent figure standing at $9.0 million for Q4 2025.

• Quarterly Payables rose 42.34% year-over-year to $9.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.0 million (up 42.34% YoY) and the FY2025 annual result came in at $9.0 million, up 42.34% from the prior year.
• Payables was $9.0 million for Q4 2025 at AVITA Medical, up from $8.1 million in the prior quarter.
• Across five years, Payables topped out at $9.0 million in Q4 2025 and bottomed at $2.4 million in Q1 2022.
• A 5-year average of $4.5 million and a median of $3.8 million in 2023 frame the typical range for Payables.
• Annual changes were most pronounced in 2022 — Payables slumped 34.11% — and 2025, when it soared 93.81%.
• AVITA Medical's Payables stood at $2.7 million in 2021, then climbed by 10.86% to $3.0 million in 2022, then climbed by 26.35% to $3.8 million in 2023, then jumped by 65.94% to $6.3 million in 2024, then surged by 42.34% to $9.0 million in 2025.
• Business Quant data shows RCEL's Payables at $9.0 million in Q4 2025, $8.1 million in Q3 2025, and $7.3 million in Q2 2025.